Financial insights of CMPS

MyFinsight

For the quarter ending 2026-03-31.

Income Statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Research and development	26,480	31,961*	27,325	30,325
General and administrative	16,424	21,873*	13,211	12,608
Total operating expenses	42,904	53,833	40,536	42,933
Loss from operations	-42,904	-53,833*	-40,536	-42,933
Fair value change of warrant liabilities	-130,916	-33,226*	101,318	2,540
Benefit from r&d tax credit	-2,477	8,570*	-3,924	-4,287
Interest income	2,419	1,953*	1,588	1,898
Interest expense	1,465	1,133*	1,105	1,151
Foreign exchange (losses) gains	-736	1,272*	-883	2,349
Other income	484	1,070*	383	-176
Total other income, net	134,095	27,818*	-97,411	4,667
Income (loss) before income taxes	91,191	-26,015*	-137,947	-38,266
Income tax benefit (expense)	-11	-2,333*	-230	137
Net income (loss)	91,202	-23,682*	-137,717	-38,403
Foreign exchange translation adjustment	-6	-281*	-605	1,729
Comprehensive income (loss)	91,196	-23,963	-138,322	-36,674

Basic EPS	0.71	-0.261	-1.44	-0.41
Diluted EPS	-0.3	-0.261	-1.44	-0.41
Basic Average Shares	110,064,581	91,834,921	95,337,993	93,341,594
Diluted Average Shares	130,266,693	91,834,921	95,337,993	93,341,594

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.